Clinical Trials Directory

Trials / Terminated

TerminatedNCT03057132

Use of 3M Cavilon Advanced Skin Protectant in the Management of Damaged Skin Around an Ostomy, Drain or Fistula

A Pilot Study Evaluating the Use of 3M Cavilon Advanced Skin Protectant in the Management of Damaged Skin Around an Ostomy, Drain or Fistula

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
1 (actual)
Sponsor
Solventum US LLC · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The objective of this pilot study is to evaluate the feasibility, safety and efficacy of 3M™ Cavilon™ Advanced Skin Protectant when used in the management of damaged skin exposed to caustic body fluids from an ostomy, drain site or fistula.

Detailed description

This is a pilot study evaluating the product, 3M™ Cavilon™ Advanced Skin Protectant, for the management of skin around an ostomy, drain and/or fistula. All subjects will receive the product for up to 14 days. The primary site must have red skin with breakdown (i.e. skin erosion and denudation or denudation of skin alone). Secondary sites can have red skin with or without breakdown. Product will be applied twice/week or more frequently if additional applications are needed due to leakage, skin irritation or standard of care. Skin assessments (including photography) will be completed at baseline and at all follow-up visits.

Conditions

Interventions

TypeNameDescription
DEVICECavilon Advanced Skin ProtectantCavilon Advanced Skin Protectant

Timeline

Start date
2016-11-01
Primary completion
2017-02-01
Completion
2017-02-01
First posted
2017-02-17
Last updated
2024-12-02
Results posted
2019-06-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03057132. Inclusion in this directory is not an endorsement.

Use of 3M Cavilon Advanced Skin Protectant in the Management of Damaged Skin Around an Ostomy, Drain or Fistula (NCT03057132) · Clinical Trials Directory